PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML) – What is it, Uses & 2026 Price in Turkey

Clinical Data Review: Comprehensive profile for PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML)

Manufacturer: WORLD MEDICINE PHARMACEUTICAL INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

OLOPATADIN HIDROKLORUR 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML) is formulated with OLOPATADIN HIDROKLORUR, a clinically established agent in medical practice.

  • Mechanism of Action: OLOPATADIN HIDROKLORUR acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to OLOPATADIN HIDROKLORUR therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML)
Barcode (GTIN) 8680199617887
Generic Name OLOPATADIN HIDROKLORUR
License Holder WORLD MEDICINE PHARMACEUTICAL INDUSTRY AND TRADE INC.
Pharmacy Retail Price 101.7 TL
⚠️ Clinical Safety Warning

Do not administer PALLADA 0.2% EYE DROPS, SOLUTION (2.5 ML) if the patient has a known hypersensitivity or allergy to OLOPATADIN HIDROKLORUR. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via WORLD MEDICINE PHARMACEUTICAL INDUSTRY AND TRADE INC..

Leave a Comment